NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-119-1992-1-CA-06 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF CA National Stage 2147608 Abandoned
NCI E-119-1992-1-DK-09 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF DK EP 93923324.3 Abandoned
NCI E-119-1992-1-EP-10 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF EP National Stage 93923324.3 Abandoned
NCI E-119-1992-1-LU-15 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF LU EP 93923324.3 Abandoned
NCI E-119-1992-1-NL-16 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF NL EP 93923324.3 Abandoned
NCI E-119-1992-1-IT-14 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF IT EP 93923324.3 Abandoned
NCI E-119-1992-1-IE-13 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF IE EP 93923324.3 Abandoned
NCI E-119-1992-1-AT-03 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF AT EP 93923324.3 Abandoned
NCI E-119-1992-1-BE-05 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF BE EP 93923324.3 Abandoned
NCI E-119-1992-1-GB-12 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF GB EP 93923324.3 Abandoned
NCI E-119-1992-1-CH-07 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF CH EP 93923324.3 Abandoned
NCI E-119-1992-1-FR-11 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF FR EP 93923324.3 Abandoned
NCI E-119-1992-1-DE-08 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF DE EP 93923324.3 Abandoned
NCI E-119-1992-1-AU-04 TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREOF AU National Stage 53254/94 Abandoned
NCI E-136-1992-0-PCT-02 TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND PRIMITIVE NEURAL MALIGNANCIES PCT PCT PCT/US1993/009858 Expired
NCI E-119-1992-1-PCT-02 No_Patent_Title PCT PCT PCT/US93/009629 Expired
NCI E-136-1992-0-EP-05 TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES EP National Stage 93923891.1 Abandoned
NCI E-136-1992-0-AU-03 TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES AU National Stage 53606/94 Abandoned
NCI E-136-1992-0-JP-06 TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND OTHER PRIMITIVE NEURAL MALIGNANCIES JP National Stage 6-510285 Abandoned
NHLBI E-143-1993-0-US-01 EFFICIENT AND SELECTIVE ADENOVIRAL-MEDIATED GENE TRANSFER INTO VASCULAR NEOINTIMA US ORD 08/136,113 6682728 Abandoned PDF
NHLBI E-129-1991-2-US-01 ADENOVIRUS-MEDIATED TRANSFER OF GENES TO THE LUNG US CIP 08/136,380 Abandoned
NCI E-221-1993-1-US-01 COMPOSITION AND METHODS FOR THERAPY AND PREVENTION OF PATHOLOGIES INCLUDING CANCER, AIDS AND ANEMIA US CIP 08/135,661 5635532 Abandoned PDF
CC E-173-1991-0-PCT-02 No_Patent_Title PCT PCT PCT/US93/009635 Abandoned
NCI E-222-1993-0-US-01 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS US ORD 08/133,574 Abandoned
NCI E-124-1992-1-US-01 ENCAPSULATED AND NON-ENCAPSULATED NITRIC OXIDE GENERATORS USED AS ANTIMICROBIAL AGENTS US CIP 08/133,601 Abandoned
NCI E-722-1984-0-US-03 ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) VIRAL ENVELOPE PRO- TEIN AND METHOD OF TESTING FOR AIDS US DIV 08/132,406 5773210 Expired PDF
NCI E-243-1992-0-PCT-02 LONG-TERM PROLIFERATION OF PRIMORDIAL GERM CELLS PCT PCT PCT/US93/09536 Abandoned
NCI E-040-1992-2-US-01 TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES US CIP 08/132,708 Abandoned
NCI E-468-1985-4-US-02 STABLE TATIII CELL LINES, TATIII GENE PRODUCTS AND ASSAY METHODS US DIV 08/131,898 5801056 Expired PDF
NIDDK E-111-1991-1-US-01 THE CLONING OF PERILIPIN PROTEINS US CIP 08/132,649 5585462 Expired PDF
NCI E-070-1990-0-US-03 USE OF PURINERGIC RECEPTOR AGONISTS AS ANTINEOPLASTIC AGENTS US FWC 08/131,033 5415873 Expired PDF
NCI E-044-1991-1-US-01 NON-MITOGENIC COMPETITIVE HGF ANTAGONIST US CIP 08/130,134 Abandoned
NCI E-076-1990-0-US-02 PSEUDOMONAS EXOTOXINS(PE) AND CONJUGATES THEREOF HAVING LOWER ANIMAL TOXICITY WITH HIGH CYTOCIDAL ACTIVITY THROUGH SUBSTITUTION OF.... US FWC 08/130,322 5512658 Expired PDF
NCI E-104-1991-1-US-01 SOLID PHASE ASSAY FOR PROTEASES US CIP 08/130,537 Abandoned
NIEHS E-210-1992-0-US-01 MUTANTS HAVING A DEFICIT OF FUNCTIONAL STEROID HORMONE RECEPTORS RECOMBINATION US ORD 08/134,132 Abandoned
NINDS E-250-1993-0-US-01 GENE THERAPY OF THE NERVOUS SYSTEM (application as filed) US ORD 08/131,085 Abandoned
NIEHS E-030-1993-0-US-01 MUTANTS WITH ORGAN-SPECIFIC DEFICIT OF FUNCTION MEDIATED BY STEROID HORMONE RECEPTORS US ORD 08/130,683 Abandoned
NCI E-317-1984-10-US-06 Nucleic Acids And Pepties Of Human Immunodeficiency Virus Type-1 (HIV-1). US DIV 08/130,565 Abandoned
NIDDK E-071-1994-1-US-01 ANALOGUE POLYPEPTIDES WITH BROAD CARCINOMA SPECIFICITY AND ANTI-SENSE POLYPEPTIDES, HYBRIDOMA, KIT AND DIAGNOSTIC, VACCINATION AND... US CIP 08/129,930 5804187 Expired PDF
NCI E-170-1989-0-US-03 DIAGNOSTIC PROBE FOR DETECTING HUMAN STOMACH CANCER US CON 08/128,782 Abandoned
NIDCR E-614-1987-0-US-09 NDNA ENCODING IGE RECEPTOR ALPHA-SUBUNIT OR FRAGMENT THEREOF US FWC 08/128,321 7202333 Expired PDF
NCI E-249-1988-0-US-04 MONOCLONAL ANTIBODY (D612) HAVING SELECTIVE REACTIVITY FOR GASTROINTESTINAL CARCINOMAS AND METHODS FOR EMPLOYING SAME. US FWC 08/127,467 Abandoned
NIDDK E-245-1992-0-PCT-07 ARALKYL DIAZABICYCLOALKANE DERIVATIVES FOR CNS DISORDERS PCT PCT PCT/US93/09108 Abandoned
NCI E-231-1993-0-US-01 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES US ORD 08/126,796 Abandoned
NCI E-128-1992-0-US-08 SPECIFIC TOLERANCE IN TRANSPLANTATION US CON 08/126,122 Abandoned
NCI E-175-1992-0-IT-13 TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER IT EP 93922310.3 Expired
NCI E-175-1992-0-IE-12 TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER IE EP 93922310.3 Expired
NCI E-175-1992-0-EP-05 TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER EP National Stage 93922310.3 Expired
NCI E-175-1992-0-MC-15 TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER MC EP 93922310.3 Expired
NCI E-175-1992-0-LU-14 TAXOL TREATMENT OF LYMPHOMAS AND BREAST CANCER LU EP 93922310.3 Expired